Bronchiolitis Clinical Trials

33 recruiting

Frequently Asked Questions

Common questions about Bronchiolitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 41 trials

Recruiting

Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome

Bronchiolitis Obliterans
M.D. Anderson Cancer Center15 enrolled1 locationNCT04604522
Recruiting

Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children

Bronchiolitis Obliterans Syndrome
The Hospital for Sick Children15 enrolled1 locationNCT04391335
Recruiting
Phase 2

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Lung DiseasesBronchiolitis Obliterans SyndromeChronic Graft Versus Host Disease+1 more
Dana-Farber Cancer Institute45 enrolled5 locationsNCT05922761
Recruiting
Not Applicable

I-DECIDE After Bronchiolitis Hospitalization

Bronchiolitis Acute
Seattle Children's Hospital2,700 enrolled56 locationsNCT07243652
Recruiting

Modern Technologies in Lower Respiratory Tract Infections in Children

Pediatric AsthmaLower Respiratory Tract and Lung InfectionsBronchiolitis Acute+3 more
Helse Møre og Romsdal HF200 enrolled2 locationsNCT07381790
Recruiting
Not Applicable

Reducing Overuse of Antibiotics With Decision Support

AsthmaPneumoniaLower Respiratory Tract Infection+1 more
Vanderbilt University Medical Center2,800 enrolled3 locationsNCT06788093
Recruiting
Not Applicable

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

AnginaAcute BronchiolitisAcute Bronchitis+8 more
University Hospital, Caen4,500 enrolled1 locationNCT07359287
Recruiting
Early Phase 1

Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells

Pediatric Bronchiolitis Obliterans
Regend Therapeutics12 enrolled1 locationNCT07239895
Recruiting

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

Hematopoietic and Lymphoid Cell NeoplasmBronchiolitis Obliterans Syndrome
Fred Hutchinson Cancer Center250 enrolled4 locationsNCT05250037
Recruiting

COVID-19 Impact on RSV Emergency Presentations

Bronchiolitis; Respiratory Syncytial Virus
University Hospitals, Leicester3,000 enrolled1 locationNCT04959734
Recruiting
Not Applicable

Bronchiolitis Clearance Airways With Seaserum

Bronchiolitis Acute
University Hospital, Brest458 enrolled8 locationsNCT06177197
Recruiting

Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients

Bronchiolitis Obliterable Syndrome
National Taiwan University Hospital600 enrolled1 locationNCT07297303
Recruiting
Phase 3

Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

Pre-Bronchiolitis Obliterans Syndrome
Renovion, Inc.100 enrolled20 locationsNCT05654922
Recruiting
Phase 2

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
University Hospital, Basel, Switzerland20 enrolled3 locationsNCT03805477
Recruiting
Not Applicable

Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms

BronchiolitisURTI
Laboratoire de la Mer1,065 enrolled32 locationsNCT07262450
Recruiting
Not Applicable

Non-Invasive Ventilation Versus Neurally-Adjusted Ventilatory Assistance (NAVA) for the Treatment of Bronchiolitis

Bronchiolitis
Montefiore Medical Center130 enrolled1 locationNCT06053684
Recruiting
Not Applicable

High Flow Nasal Cannula Weaning in Acute Bronchiolitis

Acute Bronchiolitis
Kuopio University Hospital50 enrolled4 locationsNCT06321133
Recruiting

Low-value Care, and Variation in Practice for Children Hospitalized With Bronchiolitis

Bronchiolitis
St. Justine's Hospital3,000 enrolled15 locationsNCT06506474
Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Hematopoietic Stem Cell Transplant (HSCT)Thrombotic MicroangiopathiesDiffuse Alveolar Hemorrhage+2 more
Children's Hospital Medical Center, Cincinnati2,000 enrolled9 locationsNCT04098445
Recruiting
Not Applicable

Respiratory Support and Treatment for Efficient and Cost-Effective Care

Bronchiolitis
Christopher Horvat198 enrolled1 locationNCT05909566